Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats. (Q54632091)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088878%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088878%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088878%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Barbara Huisamen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088878%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Erna Marais

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088878%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Amanda Lochner

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088878%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

1 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088878%20AND%20SRC:MED&resulttype=core&format=json

Cardiovascular Drugs and Therapy

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088878%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088878%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

13-20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088878%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088878%20AND%20SRC:MED&resulttype=core&format=json

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

Future perspectives on glucagon-like peptide-1, diabetes and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

Glucagon-like peptide 1: a potent glycogenic hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

What do we know about the secretion and degradation of incretin hormones?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

DPP-4 inhibitors and their potential role in the management of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

The islet enhancer vildagliptin: mechanisms of improved glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

The effects of glucagon-like peptide-1 on the beta cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

The role of incretins in cardiovascular control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

The temporal relationship between p38 MAPK and HSP27 activation in ischaemic and pharmacological preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

Effect of vanadate and insulin on glucose transport in isolated adult rat cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

Diet-induced endothelial dysfunction in the rat is independent of the degree of increase in total body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

Efficacy of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide (P32/98) in fatty Zucker rats with incipient and manifest impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-010-6271-7

10.1007/S10557-010-6271-7

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088878%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference